- Trials with a EudraCT protocol (528)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
528 result(s) found for: Cell Size.
Displaying page 1 of 27.
EudraCT Number: 2011-004305-24 | Sponsor Protocol Number: BCCItraconazole | Start Date*: 2012-04-18 | ||||||||||||||||
Sponsor Name:Med Uni Graz, Univ. Klinik Dermatologie,Abteilung für Allgemeine Dermatologie | ||||||||||||||||||
Full Title: Inhibition of the Hedgehog Pathway in Basal Cell Carcinomas of Patients treated with Itraconazole for Onychomycosis | ||||||||||||||||||
Medical condition: Basal cell carcinoma | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: AT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-004093-27 | Sponsor Protocol Number: ML20493 | Start Date*: 2007-04-04 | |||||||||||
Sponsor Name:Roche (Hungary) Ltd. | |||||||||||||
Full Title: A multicenter, phase II, open-label study evaluating the benefit of addition of MabThera (rituximab) to standard chemotherapies in patients with previously untreated mantle cell lymphoma. | |||||||||||||
Medical condition: Mantle cell lymphoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-001084-42 | Sponsor Protocol Number: 9090-08 | Start Date*: 2011-07-15 | ||||||||||||||||
Sponsor Name:Synta Pharmaceuticals Corp. | ||||||||||||||||||
Full Title: A Randomized, Phase IIb/III Study of Ganetespib (STA-9090) in Combination with Docetaxel versus Docetaxel alone in Subjects with Stage IIIb or IV Non-Small Cell Lung Cancer | ||||||||||||||||||
Medical condition: Non-Small Cell Lung Cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: CZ (Completed) DE (Prematurely Ended) GB (Prematurely Ended) HU (Completed) ES (Prematurely Ended) BE (Prematurely Ended) PL (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-000141-39 | Sponsor Protocol Number: 110118 | Start Date*: 2018-03-08 | |||||||||||
Sponsor Name:Merete Hædersdal | |||||||||||||
Full Title: Tolerabililty of laser-assisted cisplatin+5-fluorouracil― an exploratory proof of concept study of topical combination chemotherapy for basal cell carcinoma | |||||||||||||
Medical condition: Patients over 18 years of age with a previously untreated superficial or nodular basal cell carcinoma (BCC) on the scalp, face, extremities or trunk | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-002843-14 | Sponsor Protocol Number: 0407 | Start Date*: 2017-09-26 | |||||||||||
Sponsor Name:Bispebjerg Hospital | |||||||||||||
Full Title: Investigations of local skin reactions and safety after combined treatment of basal cell carcinoma using ablative fractional laser and ingenol mebutate - an exloratory, prospective, open-label phas... | |||||||||||||
Medical condition: Safety and local skin reactions in patients with basal cell carcinoma after combined treatment of blative fractional laser and ingenol mebutate. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022812-37 | Sponsor Protocol Number: ORH/PID/6265 | Start Date*: 2011-06-07 | |||||||||||
Sponsor Name:Oxford University Hospitals NHS Trust | |||||||||||||
Full Title: A phase 2 trial of AZD1152 in relapsed/refractory diffuse large B-cell lymphoma | |||||||||||||
Medical condition: Diffuse Large B-cell Lymphoma (DLBCL) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006964-48 | Sponsor Protocol Number: 20040215 | Start Date*: 2007-04-13 | |||||||||||
Sponsor Name:Amgen Inc | |||||||||||||
Full Title: An Open-Label, Multi-Center, Phase 2 Safety and Efficacy Study of Denosumab (AMG 162) in Subjects with Recurrent or Unresectable Giant Cell Tumor (GCT) of Bone | |||||||||||||
Medical condition: Giant Cell Tumor (GCT) of bone | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023854-35 | Sponsor Protocol Number: CD-ON-MEDI-575-1031 | Start Date*: 2011-11-07 | ||||||||||||||||
Sponsor Name:MedImmune, LLC | ||||||||||||||||||
Full Title: A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Ce... | ||||||||||||||||||
Medical condition: Previously untreated advanced non-small cell lung cancer in adults | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Prematurely Ended) HU (Completed) BG (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-001653-27 | Sponsor Protocol Number: UC_0105-1305_/_IFCT_1301 | Start Date*: 2014-07-24 | |||||||||||
Sponsor Name:UNICANCER | |||||||||||||
Full Title: Evaluation of the efficacy of high throughput genome analysis as a therapeutic decision tool for patients with metastatic non small cell lung cancer | |||||||||||||
Medical condition: Patients with metastatic non small cell lung cancer (NSCLC) in 1st line chemotherapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000639-16 | Sponsor Protocol Number: 9090-09 | Start Date*: 2012-10-17 | ||||||||||||||||
Sponsor Name:Synta Pharmaceuticals Corp | ||||||||||||||||||
Full Title: A Single Arm, Phase 2 Study of Ganetespib in Subjects with Advanced Non- Small-Cell Lung Cancer with Anaplastic Lymphoma Kinase Gene Rearrangement (ALK-Positive NSCLC) | ||||||||||||||||||
Medical condition: AKL positive advanced non-small cell lung cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) ES (Temporarily Halted) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-003214-13 | Sponsor Protocol Number: I4X-MC-JFCL | Start Date*: 2013-07-19 | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: A Randomized, Multicenter, Open-Label, Phase 2 Study of Paclitaxel-Carboplatin Chemotherapy Plus Necitumumab (IMC-11F8) Versus Paclitaxel-Carboplatin Chemotherapy Alone in the First-Line Treatme... | |||||||||||||
Medical condition: Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-000644-13 | Sponsor Protocol Number: N08AFT | Start Date*: 2008-07-10 |
Sponsor Name:NKI-AVL | ||
Full Title: A randomized, prospective trial of 2-6 weeks pre-operative hormonal treatment for hormone receptor positive breast cancer: Anastrozole +/- Fulvestrant or Tamoxifen Exposure - response in molecular ... | ||
Medical condition: Invasive Breast Cancer, tumor size >= 1 cm (NOT inflammatory breast cancer), no clues of metastatic disease, no multicentric breast cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-001468-23 | Sponsor Protocol Number: TG4010.14 | Start Date*: 2011-12-19 | ||||||||||||||||
Sponsor Name:Transgene S.A. | ||||||||||||||||||
Full Title: A Phase IIb/III randomized, double-blind, placebo-controlled study comparing first-line therapy with or without TG4010 immunotherapy product in patients with stage IV non-small cell lung cancer (NS... | ||||||||||||||||||
Medical condition: Stage IV non small cell lung cancer (NSCLC) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) HU (Completed) GB (Completed) DE (Prematurely Ended) ES (Completed) PL (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-002455-33 | Sponsor Protocol Number: D8480C00030 | Start Date*: 2006-11-13 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A Phase II, Randomised, Double-blind, Parallel Group Study to Assess the Efficacy of AZD2171 45mg Versus Placebo following 12 Weeks of Treatment in Patients with Metastatic or Recurrent Renal Cell ... | |||||||||||||
Medical condition: Renal cell carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-004262-16 | Sponsor Protocol Number: PDTMohs05 | Start Date*: 2006-01-20 | |||||||||||
Sponsor Name:Guy's & St Thomas' NHS Foundation Trust | |||||||||||||
Full Title: A trial comparing Metvix® photodynamic therapy (PDT) followed by Mohs micrographic surgery with Mohs micrographic surgery alone for the treatment of basal cell carcinoma (BCC) | |||||||||||||
Medical condition: Basal cell carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-003305-10 | Sponsor Protocol Number: MO28295 | Start Date*: 2013-03-12 | |||||||||||
Sponsor Name:F. Hoffmann-La Roche Ltd. | |||||||||||||
Full Title: A randomized, double-blinded, regimen controlled, phase II, multicenter study to assess the efficacy and safety of two different vismodegib regimens in patients with multiple basal cell carcinomas ... | |||||||||||||
Medical condition: Adult patients with multiple basal cell carcinomas (BCCs). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) DE (Completed) NL (Completed) IT (Completed) ES (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000570-22 | Sponsor Protocol Number: 20060441 | Start Date*: 2008-01-07 | ||||||||||||||||||||||||||
Sponsor Name:Amgen Inc | ||||||||||||||||||||||||||||
Full Title: A Randomized, Double-Blind, Trial of AMG 745 or Placebo for the Treatment of Cachexia in Subjects with Non-Small Cell Lung Cancer | ||||||||||||||||||||||||||||
Medical condition: Muscle cachexia due to non-small cell lung cancer (NSCLC). | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DE (Completed) SE (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-016784-11 | Sponsor Protocol Number: IMCLCP12-0917 | Start Date*: 2010-11-05 | |||||||||||
Sponsor Name:ImClone LLC | |||||||||||||
Full Title: An Open-label, Multicenter, Randomized, Phase 2 Study of a Recombinant Human Anti-VEGFR-2 Monoclonal Antibody, IMC-1121B in Combination with Platinum-based Chemotherapy versus Platinum-based Chemot... | |||||||||||||
Medical condition: Non small-cell lung cancer (NSCLC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-001961-14 | Sponsor Protocol Number: WN07DE002 | Start Date*: 2007-06-28 | |||||||||||
Sponsor Name:Greater Glasgow and Clyde [...] | |||||||||||||
Full Title: A pilot study of the treatment of facial nodular and nodulocystic basal cell carcinoma with double curettage and cautery followed by application of imiquimod to the base. | |||||||||||||
Medical condition: Basal Cell Carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-004790-25 | Sponsor Protocol Number: FD-BZK | Start Date*: 2007-12-12 | |||||||||||
Sponsor Name:University of Leipzig | |||||||||||||
Full Title: Evaluation of the benefit of fluorescence diagnostics using Metvix® and the Dyaderm system for the preoperational estimation of the lateral tumour spread in basal cell carcinomas. | |||||||||||||
Medical condition: basal cell carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.